Smoking Treatment in HIV Clinical Care Settings

Phase 3

Completed

• Conditions: Nicotine Dependence

• Registration Number: NCT00297453
• Lead Sponsor: University of California, San Francisco

Brief Summary

The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2006-02-24
• Study First Submitted QC: 2006-02-24
• Study First Posted: 2006-02-28
• Primary Completion: 2011-01
• Study Completion: 2011-01
• Status Verified: 2012-06
• Last Update Submitted: 2012-06-25
• Last Update Posted: 2012-06-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 207

Inclusion Criteria

• HIV positive
• 18 years or older
• smoking "most days" during the past month
• must be able to read English

Exclusion Criteria

• any contraindications for over-the-counter nicotine replacement treatment
• active psychotic symptoms
• severe cognitive deficits/dementia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
7 day point prevalence biochemically verified abstinence rates	3, 6, 9, and 12 months following treatment initiation

Trial Locations

Locations (1)

University of California, San Francisco; 🇺🇸 San Francisco, California, United States